We use cookies for a better user experience. Read our Privacy Policy
I Agree
Coagulation Testing Market
Rising prevalence of geriatric population, cardiovascular diseases, and blood disorders are contributing to high adoption rate of coagulation testing. Further, high demand for point of care (POC) coagulation testing and technological advancement in the coagulation testing is adding to growth of the market.
As per market analysts, blood coagulation testing market is anticipated to grow at a lucrative rate due to development of healthcare infrastructure coupled with increased healthcare expenditure.
Meanwhile, nowadays people are involved in preventive healthcare rather than proactive healthcare. Hence, people are undergoing medical tests periodically. This, in turn, is fuelling the demand for haemostasis analyzers.
Registering the trend, the players are also focussing on providing quality testing kits.
Moreover, rapid expansion of healthcare infrastructure in developed and emerging economies is one of the key driving factors aiding to growth of the market. Availability of advanced coagulation testing kit, with ability to conduct tests with high accuracy is another major driving factor.
Favourable government policies favouring best healthcare delivery in several region is promoting the use of such kits.
On the other hand, high cost of such devices is likely to limit adoption rate. Further, strict regulations for approval of testing devices are restraining the growth of the market.
However, rising demand for disposable coagulation testing equipment is presenting lucrative growth opportunities in near future.
Distribution channels are playing significant role in expansion of the coagulation testing market. The kit is easily available at offline drug stores. Meanwhile, emerging e-commerce platforms is enhancing visibility of the product.
Cost-effectiveness and highly reliable kits are likely to spur the market growth in coming years.
Coagulation Testing Market: Snapshot
Blood testing measuring the blood’s ability to clot and the time taken for the same is known as coagulation testing. Clotting disorders can cause excessive bleeding or clotting and can thus be fatal in either scenario. Coagulation testing is ordered if the physician suspects clotting disorders. There are a number of bleeding disorders which are either acquired or inherited, the most common among them being hemophilia, blood factor deficiency, etc.
The global market for coagulation testing was worth US$1,730 million in 2016, and is expected to exhibit a solid 9% CAGR in the 2017-2025 forecast period to end up at a valuation of US$3,715.8 million.
Bleeding disorders can cause abnormal bleeding, therefore it is of the utmost importance to diagnose the disorders and monitor the coagulation status. The global coagulation testing market is witnessing significant growth due to growing prevalence of blood clotting disorders in many regions and the rise in cardiovascular disorders, which can also require regular coagulation testing.
PT Testing Likely to Dominate Coagulation Testing Market
The global coagulation testing market is segmented on the basis of product type into instruments and consumables. Consumables accounted for over 80% of the global coagulation testing market in 2016. The segment is anticipated to dominate the coagulation testing market throughout the forecast period. On the basis of test type, the coagulation testing market is segmented into PT, APTT, TT, ACT, and others. The PT test segment accounted for the highest share, accounting for over 70% of the coagulation testing market in 2016.
Based on end user, the global market is segmented into hospitals and clinics, diagnostic laboratories, home care settings and others. The diagnostic laboratories segment is anticipated to expand at a fast CAGR of close to 10% during the forecast period, while hospitals and clinics are likely to remain the leading contributor to the coagulation testing market.
APAC to Exhibit Rapid CAGR despite Dominance of North America, Europe
Geographically, North America and Europe are the major regions where revenue is derived from coagulation testing. The U.S., the U.K., and Germany show high adoption rates of coagulation testing instruments such as analyzers, POC testing PT monitors, etc. due to rise in awareness amongst people about the importance of detecting and monitoring their coagulation status, high prevalence of cardiovascular diseases, and the availability of a favorable reimbursement scenario. The coagulation testing market is likely to be valued at more than US$1 bn in both North America and Europe by 2025, with the two being valued at US$678.2 mn and US$569.2 mn in 2016, respectively.
The coagulation testing market in Asia Pacific is said to be at a primary stage. It is anticipated that Asia Pacific will gain significant market share over the forecast period. Some of the key driving forces for coagulation testing market in emerging countries in the region are rising awareness, increasing population, entry of new players focusing on emerging markets, and increase in healthcare funding. The Asia Pacific market for coagulation testing is expected to exhibit a robust 10.8% CAGR over the 2017-2025 forecast period, rising from a 2016 valuation of US$358.1 mn to US$891.8 mn by 2025.
Some of the key players in the global coagulation testing market are Alere Inc., F. Hoffmann-La Roche Ltd., Abbott Laboratories, Siemens Healthineers, SYSMEX CORPORATION, Universal Biosensors, Inc., HemoSonics, LLC, and Helena Laboratories, Inc. Testing with high specificity and accuracy is likely to remain a major factor in the global coagulation testing market.
Global Coagulation Testing market is segmented as below:
|
By Product Type |
|
|
By Test Type |
|
|
By End Users |
|
|
By Region |
|
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Coagulation Testing Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.2. Market Dynamics
4.2.1. Drivers
4.2.1.1. Economic Drivers
4.2.1.2. Supply Side Drivers
4.2.1.3. Demand Side Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Key Trends
5. Global Coagulation Testing Market Analysis and Forecast, 2017-2025
5.1. Market Revenue Projections (US$ Mn)
5.2. Porter’s Five forces Analysis: Global Coagulation Testing Market
5.3. Recent Development (Industry Updates, Merger & Acquisition)
5.4. Types of Blood Clotting Disorders
5.5. Coagulation Pathways
5.6. Future Market Outlook
6. Global Coagulation Testing Market Analysis and Forecast, By Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value (US$ Mn) Forecast By Product Type
6.3.1. Instruments
6.3.2. Consumables
6.4. Market Attractiveness By Product Type
7. Global Coagulation Testing Market Analysis and Forecast, By Test Type
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value (US$ Mn) Forecast By Test Type
7.3.1. PT
7.3.2. APTT
7.3.3. TT
7.3.4. ACT
7.3.5. Others
7.4. Market Attractiveness By Test Type
8. Global Coagulation Testing Market Analysis and Forecast, By End User
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value (US$ Mn) Forecast By End User
8.3.1. Hospitals and Clinics
8.3.2. Diagnostic Laboratories
8.3.3. Home Care Settings
8.3.4. Others
8.4. Market Attractiveness By End User
9. Global Coagulation Testing Market Analysis and Forecasts, By Region
9.1. Key Findings
9.2. Market Value (US$ Mn) Forecast By Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East and Africa
9.3. Market Attractiveness By Region
10. North America Coagulation Testing Market Analysis and Forecast
10.1. Key Findings
10.2. Market Value (US$ Mn) Forecast By Product Type
10.2.1. Instruments
10.2.2. Consumables
10.3. Market Value (US$ Mn) Forecast By Test Type
10.3.1. PT
10.3.2. APTT
10.3.3. TT
10.3.4. ACT
10.3.5. Others
10.4. Market Value (US$ Mn) Forecast By End User
10.4.1. Hospitals and Clinics
10.4.2. Private Diagnostic Laboratories
10.4.3. Home Care Settings
10.4.4. Others
10.5. Market Value (US$ Mn) Forecast By Country
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product Type
10.6.2. By Test Type
10.6.3. By End User
10.6.4. By Country
11. Europe Coagulation Testing Market Analysis and Forecast
11.1. Key Findings
11.2. Market Value (US$ Mn) Forecast By Product Type
11.2.1. Instruments
11.2.2. Consumables
11.3. Market Value (US$ Mn) Forecast By Test Type
11.3.1. PT
11.3.2. APTT
11.3.3. TT
11.3.4. ACT
11.3.5. Others
11.4. Market Value (US$ Mn) Forecast By End User
11.4.1. Hospitals and Clinics
11.4.2. Diagnostic Laboratories
11.4.3. Home Care Settings
11.4.4. Others
11.5. Market Value (US$ Mn) Forecast By Country
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. By Test Type
11.6.3. By End User
11.6.4. By Country
12. Asia Pacific Coagulation Testing Market Analysis and Forecast
12.1. Key Findings
12.2. Market Value (US$ Mn) Forecast By Product Type
12.2.1. Instruments
12.2.2. Consumables
12.3. Market Value (US$ Mn) Forecast By Test Type
12.3.1. PT
12.3.2. APTT
12.3.3. TT
12.3.4. ACT
12.3.5. Others
12.4. Market Value (US$ Mn) Forecast By End User
12.4.1. Hospitals and Clinics
12.4.2. Diagnostic Laboratories
12.4.3. Home Care Settings
12.4.4. Others
12.5. Market Value (US$ Mn) Forecast By Country
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product Type
12.6.2. By Test Type
12.6.3. By End User
12.6.4. By Country
13. Latin America Coagulation Testing Market Analysis and Forecast
13.1. Key Findings
13.2. Market Value (US$ Mn) Forecast By Product Type
13.2.1. Instrument
13.2.2. Consumables
13.3. Market Value (US$ Mn) Forecast By Test Type
13.3.1. PT
13.3.2. APTT
13.3.3. TT
13.3.4. ACT
13.3.5. Others
13.4. Market Value (US$ Mn) Forecast By End User
13.4.1. Hospitals and Clinics
13.4.2. Diagnostic Laboratories
13.4.3. Home Care Settings
13.4.4. Others
13.5. Market Value (US$ Mn) Forecast By Country
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product Type
13.6.2. By Test Type
13.6.3. By End User
13.6.4. By Country
14. Middle East and Africa Coagulation Testing Market Analysis and Forecast
14.1. Key Findings
14.2. Market Value (US$ Mn) Forecast By Product Type
14.2.1. Instruments
14.2.2. Consumables
14.3. Market Value (US$ Mn) Forecast By Test Type
14.3.1. PT
14.3.2. APTT
14.3.3. TT
14.3.4. ACT
14.3.5. Others
14.4. Market Value (US$ Mn) Forecast By End User
14.4.1. Hospitals and Clinics
14.4.2. Private Diagnostic Laboratories
14.4.3. Home Care Settings
14.4.4. Others
14.5. Market Value (US$ Mn) Forecast By Country
14.5.1. Saudi Arabia
14.5.2. South Africa
14.5.3. Rest of MEA
14.6. Market Attractiveness Analysis
14.6.1. By Product Type
14.6.2. By Test Type
14.6.3. By End User
14.6.4. By Country
15. Competition Landscape
15.1. Market Player – Competition Matrix
15.2. Market Share Analysis By Company (2016)
15.3. Company Profiles
15.3.1. F. Hoffmann-La Roche Ltd.
15.3.1.1 Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2 Product Portfolio
15.3.1.3 SWOT Analysis
15.3.1.4 Financial Overview
15.3.1.5 Strategic Overview
15.3.2. Abbott Laboratories
15.3.1.1 Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2 Product Portfolio
15.3.1.3 SWOT Analysis
15.3.1.4 Financial Overview
15.3.1.5 Strategic Overview
15.3.3. Siemens Healthineers
15.3.1.1 Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2 Product Portfolio
15.3.1.3 SWOT Analysis
15.3.1.4 Financial Overview
15.3.1.5 Strategic Overview
15.3.4. SYSMEX CORPORATION
15.3.1.1 Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2 Product Portfolio5
15.3.1.3 SWOT Analysis
15.3.1.4 Financial Overview
15.3.1.5 Strategic Overview
15.3.5. Universal Biosensors, Inc.
15.3.1.1 Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2 Product Portfolio
15.3.1.3 SWOT Analysis
15.3.1.4 Financial Overview
15.3.1.5 Strategic Overview
15.3.6. HemoSonics, LLC
15.3.1.1 Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2 Product Portfolio
15.3.1.3 SWOT Analysis
15.3.1.4 Financial Overview
15.3.1.5 Strategic Overview
15.3.7. Thermo Fisher Scientific, Inc.
15.3.1.1 Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2 Product Portfolio
15.3.1.3 SWOT Analysis
15.3.1.4 Financial Overview
15.3.1.5 Strategic Overview
15.3.8. Helena Laboratories, Inc.
15.3.1.1 Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2 Product Portfolio
15.3.1.3 SWOT Analysis
15.3.1.4 Financial Overview
15.3.1.5 Strategic Overview
15.3.9. Alere Inc.
15.3.1.1 Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2 Product Portfolio
15.3.1.3 SWOT Analysis
15.3.1.4 Financial Overview
15.3.1.5 Strategic Overview
15.3.10. Randox Laboratories Ltd.
15.3.1.1 Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2 Product Portfolio
15.3.1.3 SWOT Analysis
15.3.1.4 Financial Overview
15.3.1.5 Strategic Overview
15.3.11. HORIBA, Ltd
15.3.1.1 Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2 Product Portfolio
15.3.1.3 SWOT Analysis
15.3.1.4 Financial Overview
15.3.1.5 Strategic Overview
15.3.12. Agappe Diagnostics Ltd.
15.3.1.1 Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2 Product Portfolio
15.3.1.3 SWOT Analysis
15.3.1.4 Financial Overview
15.3.1.5 Strategic Overview
15.3.13. Medtronic plc
15.3.1.1 Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2 Product Portfolio
15.3.1.3 SWOT Analysis
15.3.1.4 Financial Overview
15.3.1.5 Strategic Overview
List of Tables
Table 01: Acronyms Used
Table 02: Global Coagulation Testing Market Value (US$ Mn) Forecast, by Product Type, 2015–2025
Table 03: Global Coagulation Testing Market Value (US$ Mn) Forecast, by Test Types, 2015–2025
Table 04: Global Coagulation Testing Market Size (US$ Mn) Forecast, by End Users, 2015–2025
Table 05: Global coagulation testing Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 06: North America Coagulation Testing Market Value (US$ Mn) Forecast, by Product Type, 2015–2025
Table 07: North America Coagulation Testing Market Value (US$ Mn) Forecast, by Test Types,2015–2025
Table 08: North America Coagulation Testing Market Value (US$ Mn) Forecast, by End Users, 2015–2025
Table 09: North America Coagulation Testing Market Value (US$ Mn) Forecast, by Country, 2015–2025
Table 10: Europe Coagulation Testing Market Value (US$ Mn) Forecast, by Product Type, 2015–2025
Table 11: Europe Coagulation Testing Market Value (US$ Mn) Forecast, by Test Types,2015–2025
Table 12: Europe Coagulation Testing Market Value (US$ Mn) Forecast, by End Users, 2015–2025
Table 13: Europe Coagulation Testing Market Value (US$ Mn) Forecast, by Country, 2015–2025
Table 14: Asia Pacific Coagulation Testing Market Value (US$ Mn) Forecast, by Product Type, 2015–2025
Table 15: Asia Pacific Coagulation Testing Market Value (US$ Mn) Forecast, by Test Types,2015–2025
Table 16: Asia Pacific Coagulation Testing Market Value (US$ Mn) Forecast, by End Users, 2015–2025
Table 17: Asia Pacific Coagulation Testing Market Value (US$ Mn) Forecast, by Country, 2015–2025
Table 18: Latin America Coagulation Testing Market Value (US$ Mn) Forecast, by Product Type, 2015–2025
Table 19: Latin America Coagulation Testing Market Value (US$ Mn) Forecast, by Test Types,2015–2025
Table 20: Latin America Coagulation Testing Market Value (US$ Mn) Forecast, by End Users, 2015–2025
Table 21: Latin America Coagulation Testing Market Value (US$ Mn) Forecast, by Country, 2015–2025
Table 22: Middle East & Africa Coagulation Testing Market Value (US$ Mn) Forecast, by Product Type, 2015–2025
Table 23: Middle East & Africa Coagulation Testing Market Value (US$ Mn) Forecast, by Test Types,2015–2025
Table 24: Middle East & Africa Coagulation Testing Market Value (US$ Mn) Forecast, by End Users, 2015–2025
Table 25: Middle East & Africa Coagulation Testing Market Value (US$ Mn) Forecast, by Country, 2015–2025
List of Figures
Figure 01: Global Coagulation Testing Market By Test types, Market Size (US$ Mn), 2016 (A)
Figure 02: Global Coagulation Testing Market Revenue (%), by End Users, 2016 (A)
Figure 03: Distribution of Coagulation Testing Market by Region, 2016 and 2025
Figure 04: Global Coagulation Testing Market Size (US$ Mn) Forecast, 2015–2025
Figure 05: Porter’s Five Forces Analysis
Figure 06: Market Value Share, by Product Type (2016)
Figure 07: Market Value Share, by Test Types (2016)
Figure 08: Market Value Share, by End Users(2016)
Figure 09: Global Coagulation Testing Market Value Share Analysis, by Product Type, 2016 and 2025
Figure 10: Global Coagulation Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Instruments, 2015–2025
Figure 11: Global Coagulation Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Consumables, 2015–2025
Figure 12: Global Coagulation Testing Market Attractiveness Analysis, by Product Type
Figure 13: Global Coagulation Testing Market Value Share Analysis, by Test Types, 2016 and 2025
Figure 14: Global coagulation testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), PT test, 2015–2025
Figure 15: Global coagulation testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by APTT Test, 2015–2025
Figure 16: Global coagulation testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by TT Test, 2015–2025
Figure 17: Global coagulation testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by ACT test, 2015–2025
Figure 18: Global coagulation testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2015–2025
Figure 19: Global Coagulation Testing Market Attractiveness Analysis, by Test Types
Figure 20: Global coagulation testing Market Value Share Analysis, by End Users, 2016 and 2025
Figure 21: Global coagulation testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospital and Clinics, 2015–2025
Figure 22: Global coagulation testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diagnostic Laboratories, 2015–2025
Figure 23: Global coagulation testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Home care settings, 2015–2025
Figure 24: Global coagulation testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2015–2025
Figure 25: Global coagulation testing Market Attractiveness Analysis, by End Users, 2017–2025
Figure 26: Global Coagulation Testing Market Scenario
Figure 27: Global coagulation testing Market Value Share Analysis, by Region, 2016 and 2025
Figure 28: Global coagulation testing Market Attractiveness Analysis, by Region
Figure 29: North America Coagulation Testing Market Size (US$ Mn) Forecast, 2015–2025
Figure 30: North America Coagulation Testing Market Value Share Analysis, by Product Type, 2016 and 2025
Figure 31: North America Coagulation Testing Market Value Share Analysis, by Test Types, 2016 and 2025
Figure 32: North America Coagulation Testing Market Value Share Analysis, by End Users, 2016 and 2025
Figure 33: North America Coagulation Testing Market Value Share Analysis, by Country, 2016 and 2025
Figure 34: North America Coagulation Testing Market Attractiveness Analysis, by Product Type
Figure 35: North America Coagulation Testing Market Attractiveness Analysis, by Test Types
Figure 36: North America Coagulation Testing Market Attractiveness Analysis, by End Users
Figure 37: North America Market Attractiveness Analysis, by Country
Figure 38: Europe Coagulation Testing Market Size (US$ Mn) Forecast, 2015–2025
Figure 39: Europe Coagulation Testing Market Value Share Analysis, by Product Type, 2016 and 2025
Figure 40: Europe Coagulation Testing Market Value Share Analysis, by Test Types, 2016 and 2025
Figure 41: Europe Coagulation Testing Market Value Share Analysis, by End Users, 2016 and 2025
Figure 42: Europe Coagulation Testing Market Value Share Analysis, by Country, 2016 and 2025
Figure 43: Europe Coagulation Testing Market Attractiveness Analysis, by Product Type
Figure 44: Europe Coagulation Testing Market Attractiveness Analysis, by Test Type
Figure 45: Europe Coagulation Testing Market Attractiveness Analysis, by End Users
Figure 46: Europe Market Attractiveness Analysis, by Country
Figure 47: Asia Pacific Coagulation Testing Market Size (US$ Mn) Forecast, 2015–2025
Figure 48: Asia Pacific Coagulation Testing Market Value Share Analysis, by Product Type, 2016 and 2025
Figure 49: Asia Pacific Coagulation Testing Market Value Share Analysis, by Test Types, 2016 and 2025
Figure 50: Asia Pacific Coagulation Testing Market Value Share Analysis, by End Users, 2016 and 2025
Figure 51: Asia Pacific Coagulation Testing Market Value Share Analysis, by Country, 2016 and 2025
Figure 52: Asia Pacific Coagulation Testing Market Attractiveness Analysis, by Product Type
Figure 53: Asia Pacific Coagulation Testing Market Attractiveness Analysis, by Test Types
Figure 54: Asia Pacific Coagulation Testing Market Attractiveness Analysis, by End Users
Figure 55: Asia Pacific Market Attractiveness Analysis, by Country
Figure 56: Latin America Coagulation Testing Market Size (US$ Mn) Forecast, 2017–2025eval
Figure 57: Latin America Coagulation Testing Market Value Share Analysis, by Product Type, 2016 and 2025
Figure 58: Latin America Coagulation Testing Market Value Share Analysis, by Test Types, 2016 and 2025
Figure 59: Latin America Coagulation Testing Market Value Share Analysis, by End Users, 2016 and 2025
Figure 60: Latin America Coagulation Testing Market Value Share Analysis, by Country, 2016 and 2025
Figure 61: Latin America Coagulation Testing Market Attractiveness Analysis, by Product Type
Figure 62: Latin America Coagulation Testing Market Attractiveness Analysis, by Test Types
Figure 63: Latin America Coagulation Testing Market Attractiveness Analysis, by End Users
Figure 64: Latin America Market Attractiveness Analysis, by Country
Figure 65: Middle East & Africa Coagulation Testing Market Size (US$ Mn) Forecast, 2015–2025
Figure 66: Middle East & Africa Coagulation Testing Market Value Share Analysis, by Product Type, 2016 and 2025
Figure 67: Middle East & Africa Coagulation Testing Market Value Share Analysis, by Test Types, 2016 and 2025
Figure 68: Middle East & Africa Coagulation Testing Market Value Share Analysis, by End Users, 2016 and 2025
Figure 69: Middle East & Africa Coagulation Testing Market Value Share Analysis, by Country, 2016 and 2025
Figure 70: Middle East & Africa Coagulation Testing Market Attractiveness Analysis, by Product Type
Figure 71: Middle East & Africa Coagulation Testing Market Attractiveness Analysis, by Test Types
Figure 72: Middle East & Africa Coagulation Testing Market Attractiveness Analysis, by End Users
Figure 73: Middle East & Africa Market Attractiveness Analysis, by Country
Figure 74: Global Coagulation Testing Market Share Analysis, by Company (2016)
Figure 75: Breakdown of Net Sales, by Segment, 2016,(F. Hoffmann-La Roche)
Figure 76: Revenue (US$ Bn) & Y-o-Y Growth (%), 2013–2016, ,(F. Hoffmann-La Roche)
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
*86 figures and 60 tables includes